Latest filing published 24 Feb 2020 for Iradimed CORP, €42k.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 3 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +32.9%Entry US$14.64 · Close at T+365 US$19.45
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Steven M. Nardi: trading record in brief
Steven M. Nardi appears in our data through filings on Iradimed Corp shares, published by SEC (Form 4). In total, 53 filings cover trades dated from 21 July 2014 to 20 February 2020.
On the open market, the record shows 4 purchases worth €22k and 18 sales worth €589k. Taken together, the sales exceed the purchases by €568k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 21 share grants and 10 option exercises. In 2020 alone, the filings show no purchases and 1 sale.
Half of the purchases are above €5,300 and half below. For 3 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 100% of cases, with a median move of +10.7%. These figures describe past trades and do not predict future prices.
The record was last updated on 24 February 2020 with an open-market sale (€42k) in Iradimed Corp. The latest purchase dates back some time: it was published 4,331 days ago, on 30 December 2014. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Steven M. Nardi
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,715 shares@ US$26.1945.4% of flowCommon StockSEC:0000898432-20-000124:0
- 388 sharesCommon StockSEC:0000898432-20-000019:0
- 95 shares@ US$23.380.6% of flowCommon StockSEC:0000898432-20-000019:1
- 750 sharesCommon StockSEC:0000898432-19-001511:0
- 183 shares@ US$25.671.3% of flowCommon StockSEC:0000898432-19-001511:1
- 393 sharesCommon StockSEC:0000898432-19-001434:0
- 96 shares@ US$22.880.6% of flowCommon StockSEC:0000898432-19-001434:1
- 738 sharesCommon StockSEC:0000898432-19-001350:0
- 180 shares@ US$22.281.1% of flowCommon StockSEC:0000898432-19-001350:1
- 1,250 shares@ US$9.843.5% of flowCommon StockSEC:0000898432-19-001295:0
- 1,250 shares@ US$24.368.5% of flowCommon StockSEC:0000898432-19-001295:1
- 1,418 shares@ US$26.0710.1% of flowCommon StockSEC:0000898432-19-000364:0
- 388 sharesCommon StockSEC:0000898432-19-000013:0
- 95 shares@ US$24.460.6% of flowCommon StockSEC:0000898432-19-000013:1
- 183 shares@ US$27.021.4% of flowCommon StockSEC:0000898432-18-001518:1
- 750 sharesCommon StockSEC:0000898432-18-001518:0
- 180 shares@ US$26.781.3% of flowCommon StockSEC:0000898432-18-001416:1
- 738 sharesCommon StockSEC:0000898432-18-001416:0
- 4,376 shares@ US$1.481.7% of flowCommon StockSEC:0000898432-18-000887:0
- 2,500 shares@ US$9.846.6% of flowCommon StockSEC:0000898432-18-000887:1
- 7,662 shares@ US$23.8048.7% of flowCommon StockSEC:0000898432-18-000887:2
- 388 sharesCommon StockSEC:0000898432-18-000009:0
- 107 shares@ US$15.150.3% of flowCommon StockSEC:0000898432-18-000009:1
- 750 sharesCommon StockSEC:0000898432-17-001309:0
- 245 shares@ US$13.100.7% of flowCommon StockSEC:0000898432-17-001309:1
25 of 51 declarations